成功房室瓣修复改善单心室患者临床结局:多状态模型分析
该研究回顾1998至2022年716例单心室患者,采用多状态模型分析房室瓣反流出现与房室瓣修复对生存的影响。195例出现房室瓣反流,155例接受修复,其中69例修复成功;
要点
- 成功房室瓣修复使单心室合并房室瓣反流患者死亡/心脏移植风险降低84%。
- 在双向腔肺分流(BCPS)时或之后行房室瓣修复,生存获益明确。
- BCPS前修复除非成功,否则风险较高;心室功能障碍与生存不良强相关。
核心结论
- 成功房室瓣修复可显著降低单心室合并房室瓣反流患者的死亡/心脏移植风险,修复时机与成败是长期生存的关键决定因素。
研究设计与样本
- 回顾性队列研究,纳入1998至2022年716例接受手术姑息的单心室患者,按房室瓣反流出现时机、房室瓣修复及双向腔肺分流(BCPS)分类,采用含时依变量的多状态模型分析临床轨迹,Kaplan-Meier与竞争风险分析估计无移植生存。
主要发现
- 716例中195例出现房室瓣反流,155例接受房室瓣修复,其中69例修复成功。
- 心室功能障碍无论原发或继发于房室瓣反流,均与生存不良强相关。
临床怎么用
- 对单心室合并房室瓣反流患者,应争取实现成功的房室瓣修复,并关注在BCPS时或之后修复的时机选择。
- BCPS前修复需谨慎评估,除非预期修复成功,否则风险较高;心室功能障碍者需强化管理。
局限性
- 为单中心回顾性研究,成功修复定义限定为修复后至少1年无反流、死亡或心脏移植,可能存在选择偏倚与随访差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluated the impact of atrioventricular valve regurgitation (AVVR) onset and atrioventricular valve repair (AVVrep) on survival in single-ventricle (SV) patients using a multistate model and analyzed how successful AVVrep alters clinical course. METHODS: We retrospectively reviewed all SV patients who underwent surgical palliations from 1998 to 2022, classified based on timing of AVVR onset, AVVrep, and bidirectional cavopulmonary shunt (BCPS). AVVrep was defined as successful if patients remained free from AVVR, death, or heart transplant (HTx) for at least 1 year after repair. Clinical trajectories were analyzed using a multistate model incorporating time-dependent variables. Transplant-free survival was estimated using Kaplan-Meier and competing-risk analyses. RESULTS: Among 716 SV patients, AVVR developed in 195, and 155 underwent AVVrep. Of these, 69 had a successful repair. Successful AVVrep significantly reduced risk of death/HTx (hazard ratio [HR], 0.16; 95% CI, 0.07-0.40, P < .001), achieving survival comparable to patients without AVVR (P = .94). In patients with AVVR onset before BCPS, reduction in the risk of death/HTx could be achievable if those requiring AVVrep before BCPS reached BCPS (HR, 0.18; 95% CI, 0.05-0.65; P = .009) and when AVVrep was performed at or after BCPS (HR, 0.24; 95% CI, 0.11-0.53; P < .001). Ventricular dysfunction, whether primary or secondary to AVVR, was strongly associated with inferior survival. CONCLUSIONS: Successful AVVrep potentially reduces risk of death/HTx by 84% in SV patients with AVVR onset, particularly when performed at or after BCPS, resulting in comparable survival to those with no AVVR. Early AVVrep before BCPS confers high risk unless AVVrep is successful. Timing and success of AVVrep are critical determinants of long-term survival.
引用
- Kadowaki S, Steve Fan CP, Venet M, et al. Successful Atrioventricular Valve Repair Modifies Clinical Outcomes in Single-Ventricle Patients: Multistate Model Analysis. Ann Thorac Surg. 2026. PMID: 41850471. doi:10.1016/j.athoracsur.2026.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。